Third Affiliated Hospital, Sun Yat-Sen University
261
31
35
47
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
2.3%
6 terminated/withdrawn out of 261 trials
88.7%
+2.2% vs industry average
16%
43 trials in Phase 3/4
6%
3 of 47 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (261)
Efficacy and Safety of Cytokine Adsorption and Plasma Exchange in Patients With ACLF and Sepsis
Role: lead
Real-World Cohort Study of Cardiopulmonary Function in Chinese Patients With Cardiovascular Disease: CPET Evaluation and Five-Year Prognostic Follow-Up Based on a Multicenter Structured Data Platform
Role: collaborator
Efficacy and Safety of Low-dose Bevacizumab Plus Adebrelimab Combined With Transarterial Chemoembolization Followed by Hepatic Arterial Infusion Chemotherapy (TACE-HAIC) as First-line Treatment for Unresectable Hepatocellular Carcinoma: A Single-arm Phase 2 Trial
Role: lead
PaCIFiC-CUP Classifies Cancer of Unknown Primary
Role: collaborator
Low-Dose Bevacizumab and Atezolizumab Combined With TACE-HAIC in Unresectable Hepatocellular Carcinoma
Role: lead
Hospital-Based Management of Patients With Chronic Hepatitis B Virus Infection
Role: lead
Optimizing Endoscopic and Interventional Treatment for Portal Hypertensive Bleeding
Role: collaborator
PT-MSCs Exosome Injection in the Treatment of Chronic-to-acute Liver Failure
Role: lead
Establishing a Virtual Health Community Management Model for Pre-Diabetes Patients
Role: lead
A Study on Multimodal Prognostic Scoring of Advanced PDAC.
Role: collaborator
Exploring the Efficacy and Safety of Ofatumumab in Patients With Relapsing Multiple Sclerosis (RMS) and Its Impact on Serum Neurofilament Light Chain (sNfL) Levels
Role: lead
Effectiveness of a Virtual Health Management Community (VHMC) for Pre-diabetes in China
Role: lead
2025 Hypoglycemia Early-Warning and Physician-Nurse Collaborative Management Trial in Type 2 Diabetes
Role: lead
Efficacy and Safety of an Intelligent Insulin-Dosing Decision Support System for Glycemic Control in Patients With Type 2 Diabetes: A Randomized Controlled Study
Role: lead
Transarterial Chemoembolization With Low-Dose Bevacizumab Plus Atezolizumab as First-Line Treatment for Unresectable Hepatocellular Carcinoma
Role: lead
Efficacy and Safety of Tranexamic Acid in Adult Liver Transplantation---ESTA Trial
Role: collaborator
Treatment of Spinal Cord Injury Using Autologous Concentrated Growth Factors
Role: lead
Safety and Early Efficacy of iPSC-Derived Motor Neuron Progenitor Cells (XS228) in Subacute Spinal Cord Injury: A Phase I Trial
Role: collaborator
Efficacy of iPSC-Derived Motor Neuron Cells (XS228) in Subacute Spinal Cord Injury: A Phase II Randomized Controlled Trial
Role: collaborator
Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B
Role: collaborator